Peter Schmid
MD, PhD
Professor of Cancer Medicine, Director St Bartholomew's Breast Cancer Centre
👥Biography 个人简介
Peter Schmid led the KEYNOTE-522 trial establishing neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab as a standard in high risk early triple-negative breast cancer. His work demonstrated improvements in pathologic complete response and event-free survival. He directs the breast cancer center at St Bartholomew's in London.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Peter Schmid 的研究动态
Follow Peter Schmid's research updates
留下邮箱，当我们发布与 Peter Schmid（Barts Cancer Institute, Queen Mary University of London）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment